BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 8, 2019
View Archived Issues
Ketotifen-releasing contact lens for the management of ocular allergy itch
Read More
Samumed presents phase IIb results for SM-04690 in knee osteoarthritis
Read More
New epigenetic immunomodulator for SWI/SNF-deficient cancers presented
Read More
Patient enrollment ongoing in first-in-human study of SL-279252
Read More
COM-701 safe in initial cohorts of phase I study
Read More
G protein-coupled receptor 35 agonists described by Okayama University and Kogakuin University
Read More
Bio Pep synthesizes new therapeutic oligopeptides
Read More
Arresting the transition from acute to chronic pain
Read More
New IL-10 production enhancers patented by Daiichi Sankyo
Read More
Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine patent RORC agonists
Read More
Keeping bacteria from genome gambling slows resistance evolution
Read More
DE Shaw Research discovers GTPase KRas inhibitors
Read More
Arcus Biosciences presents AB-680, a potent and selective inhibitor of CD73
Read More
ITRI-E-212 demonstrates promising safety and IOP-lowering effects in vivo
Read More
Eli Lilly presents population PK data for LY-3295668 erbumine in patients with advanced solid tumors
Read More
Phase Ia data presented for anti-EGFR antibody-drug conjugate AVID-100
Read More
DNA methylation marks in ELOVL2 gene as promising epigenetic biomarkers of early-stage AD
Read More
CE mark for radioenhancer Hensify for locally advanced soft tissue sarcoma
Read More
Celltrion and iProgen partner to develop ADCs
Read More
Phase II trial evaluates use of radiosensitizer AGuIX in brain metastases
Read More
First-in-human study finds ONO-5788 well tolerated in single ascending doses
Read More
New phase I trial studies PD-1 antibody AMG-404 in advanced solid tumors
Read More
United Therapeutics discontinues development of esuberaprost based on BEAT results in PAH
Read More
AstraZeneca PI3Kgamma inhibitor AZD-3458 reverts tumor resistance to immunotherapy in vivo
Read More
Preclinical study of DLL3/CD3 IgG-like T-cell engager for small cell lung cancer
Read More